RxDoctor Payments Data

Cirilo Adao

Addiction Medicine · Lakewood, WANPI 1811920010

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 45.1% of the total. Reporting peaked in 2021 at $939 and has fallen 69.0% since, to $291 in 2025. Among addiction medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,564in general payments, 2019–2025

Across 135 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$256
  • AstraZeneca$251
  • Kowa Pharmaceuticals America, Inc.$211
  • Amarin Pharma, Inc.$131
  • Orexo US, Inc.$86
  • plus $473 from 15 others

What the payments were for

  • Food & beverage$2,564100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,564 in reported general payments places this provider in the 90th percentile of 39 addiction medicine providers in Washington.

See all addiction medicine providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuboxoneBuprenorphine Hcl/Naloxone Hcl13$7,342
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$1,565
Atorvastatin Calcium86$779
Gabapentin25$742
Albuterol Sulfate HfaAlbuterol Sulfate26$595
Rosuvastatin Calcium50$546
Amlodipine Besylate64$545
Metformin Hcl61$480
Omeprazole13$391
Doxepin Hcl13$374
Losartan Potassium59$374
Lisinopril35$322
Metoprolol Succinate40$321
Levothyroxine Sodium38$283
Pantoprazole Sodium17$281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Suboxone$15$7,34213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 39 addiction medicine providers in Washington.

Other addiction medicine in Lakewood

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →